title: Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis.
abstract: OBJECTIVE
  Ulcerative colitis (UC) is a chronic inflammatory disease characterized by recurrent inflammation and ulcerations of colonic mucosa and an inappropriate and delayed healing. Adenosine deaminase (ADA) is a cytoplasmic enzyme involved in the catabolism of purine bases, capable of catalyzing the deamination of adenosine, forming inosine in the result process. Although ADA has been shown to increase in several inflammatory conditions, there are no literature data indicating an alteration in UC.
  
  
  METHODS
  This study evaluated the activity of total ADA in serum of 43 patients with UC and 18 healthy controls. Patients' age, disease duration, drug intake, and other medical history were all noted for each subject. Complete blood count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) were determined for both patients and controls. Correlation analysis was also performed between ADA and other inflammation markers of UC.
  
  
  RESULTS
  Serum mean ADA levels were 11.12 ± 2.03 and 7.99 ± 2.04 U/l for patients with UC in active state and in remission and 8.55 ± 2.26 U/l in the healthy control group. Mean serum ADA levels were significantly elevated in active UC patients compared with patients with UC in remission and control groups. Overall accuracy of ADA in determination of active UC was 83.7 with sensitivity 83.3%, specificity 84.2%.
  
  
  CONCLUSIONS
  Serum ADA levels were found to be elevated in UC patients in active state suggesting a partial role of activated T-cell response in the disease pathophysiology. Further randomized controlled studies are warranted to demonstrate the role of ADA in UC patients, with a special interest in specifically targeted therapies against ADA for achieving disease remission.
authors.affiliation: Department of Gastroenterology, Turkiye Yuksek İhtisas Training and Research Hospital, Ankara, Turkey. yavuzbeyaz@yahoo.com
authors.forename: Yavuz
authors.initials: Y
authors.lastname: Beyazit
authors.forename: Seyfettin
authors.initials: S
authors.lastname: Koklu
authors.forename: Adnan
authors.initials: A
authors.lastname: Tas
authors.forename: Tugrul
authors.initials: T
authors.lastname: Purnak
authors.forename: Abdurrahim
authors.initials: A
authors.lastname: Sayilir
authors.forename: Mevlut
authors.initials: M
authors.lastname: Kurt
authors.forename: Turan
authors.initials: T
authors.lastname: Turhan
authors.forename: Tugrul
authors.initials: T
authors.lastname: Celik
authors.forename: Burak
authors.initials: B
authors.lastname: Suvak
authors.forename: Serkan
authors.initials: S
authors.lastname: Torun
authors.forename: Erdem
authors.initials: E
authors.lastname: Akbal
mesh_terms: D000243:Adenosine Deaminase / Q000097:blood*; D000293:Adolescent; D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D003093:Colitis, Ulcerative / Q000097:blood* / Q000145:classification; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D055815:Young Adult
chemical_list: D015415:Biomarkers; C548482:ADA protein, human; D000243:Adenosine Deaminase